Economic Atlas
Companies/Cannabis Global Inc.
Company profile

Cannabis Global Inc.

OTC: CBGL · Healthcare · Drug Manufacturers - Specialty & Generic
PublicHQ Los Angeles, CA · Los AngelesCIK 0001413488Reports USD
#822 of 1,418 Healthcare companies by revenuetop-decile growth
EA Score
——
Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$7.8M
Employees
3
as of 2026-08-28
Market cap
$656.4k
as of 2026-08-28

Financials — latest annual

SEC EDGAR · USD-normalized
ConceptUSDNativeFY
Revenue$1.6M$1.6M2021
Net income-$7.8M-$7.8M2021
Operating income-$1.9M-$1.9M2021
Total assets$11.3M$11.3M2021
Liabilities$10.0M$10.0M2021
Equity-$2.2M-$2.2M2021

Revenue trend

FY2012 – FY2021 · USD
FY12
FY12
FY13
FY14
FY19
FY19
FY20
FY21

Revenue by segment

Filed disclosures · FY2021
By product
Product Sales100%
By geography

Not disclosed.

The read

What is Cannabis Global Inc.’s revenue?

Cannabis Global Inc. booked $1.6M in FY2021 revenue, growing 5829% year over year — faster than 99% of Healthcare companies we track, at a -489.4% net margin.

Peers · Healthcare
Rani Therapeutics Holdings, Inc.41DEBR Systems, Inc.34DJames E. Wagner Cultivation Corporation——BG Medicine, Inc.——Acura Pharmaceuticals, Inc.——Celldex Therapeutics, Inc.58C
Neighbors
Los Angeles →
The Walt Disney Company$94.4B72BPublic Storage$4.8B80B+Southern California Gas Company PFD SER A 6%——Ares Management Corporation$5.6B68BLive Nation Entertainment, Inc.$25.2B76B+Rocket Lab USA, Inc.$601.8M50D
Key facts
CEOEdward F. Manolos
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersLos Angeles, CA
ExchangeOTC: CBGL
Employees3
IPO date2008-06-19
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.